Overview

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

Status:
Completed
Trial end date:
2019-01-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate comparative efficacy and safety of rivaroxaban to standard of care in children with acute venous thromboembolism.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Collaborator:
Janssen Research & Development, LLC
Treatments:
Dalteparin
Heparin, Low-Molecular-Weight
Rivaroxaban